batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Merck hits another Keynote in perioperative lung 10 October 2023 Roche keeps expanding its SERD phase 3 programme 5 October 2023 The second phase 3 Claudin18.2 asset belongs to Transcenta 4 October 2023 The end of Exkivity is another win for Rybrevant 3 October 2023 Lilly makes its Point in radiopharmaceuticals 3 October 2023 Against the odds biopharma throws all it can at CD47 26 September 2023 AbbVie ends its third oncology deal in two weeks 26 September 2023 Roche slips further behind in perioperative lung cancer 25 September 2023 Load More